<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02715037</url>
  </required_header>
  <id_info>
    <org_study_id>52683</org_study_id>
    <nct_id>NCT02715037</nct_id>
  </id_info>
  <brief_title>Microbiology of Severe Acute Tonsillitis, Peritonsillar Cellulitis, and Infectious Mononucleosis</brief_title>
  <official_title>Mikrobiologi Ved svær Akut Tonsillit, peritonsillær Phlegmone og infektiøs Mononukleose</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tejs Ehlers Klug</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Statens Serum Institut</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Aarhus University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective, observational study of the microbiology of patients referred to a tertiary care
      center with severe acute tonsillitis, peritonsillar cellulitis, or infectious mononucleosis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients referred to tertiary care centers with acute throat infections are most often
      treated with antibiotics. However, very little is know concerning the prevalent pathogens in
      patients with acute throat infections without abscess formation. Evidence suggests that
      Fusobacterium necrophorum plays an important role in complications of acute tonsillitis (e.g.
      peritonsillar abscess), but also uncomplicated acute tonsillitis.

      This study aims to explore the throat microbiology of patients with severe acute tonsillitis,
      peritonsillar cellulitis, or infectious mononucleosis with a special attention to a possible
      role of Fusobacterium necrophorum.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>June 2016</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">May 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Prevalence of Fusobacterium necrophorum in throat swab cultures</measure>
    <time_frame>At acute consultation (day 0)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of participants with recurrent throat infections (questionnaire)</measure>
    <time_frame>Six months after acute consultation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants without eradication of throat pathogens (throat cultures)</measure>
    <time_frame>14-28 days after acute consultation</time_frame>
    <description>&quot;Throat pathogens&quot;: Fusobacterium necrophorum, Beta-hemolytical streptococci, A. hemolyticum</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants with complications of severe acute tonsillitis, peritonsillar cellulitis, and infectious mononucleosis</measure>
    <time_frame>14-28 days after acute consultation</time_frame>
    <description>&quot;Complications&quot;: admission, abscess Development, change of antibiotic treatment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prevalence of anti-Fusobacterium necrophorum antibody Development (two-fold or higher increase in antibody level) (blood samples)</measure>
    <time_frame>In acute and convalescent sera (day 0 and 14-28)</time_frame>
    <description>Comparison of the prevalence of antibody Development (two-fold or higher increase in antibody level) between patients with recovery of Fusobacterium necrophorum in throat swabs versus patients without recovery of Fusobacterium necrophorum in throat swabs</description>
  </secondary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Anticipated">350</enrollment>
  <condition>Acute Tonsillitis</condition>
  <condition>Peritonsillar Cellulitis</condition>
  <condition>Infectious Mononucleosis</condition>
  <arm_group>
    <arm_group_label>Acute tonsillitis</arm_group_label>
    <description>Patients referred to the tertiary care center with severe acute tonsillitis but without peritonsillar cellulitis, infectious mononucleosis, or abscess formation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Peritonsillar cellulitis</arm_group_label>
    <description>Patients referred to the tertiary care center with severe acute tonsillitis and peritonsillar cellulitis but without abscess formation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Infectious mononucleosis</arm_group_label>
    <description>Patients referred to the tertiary care center with acute tonsillitis and biochemical or serological signs of infectious mononucleosis but without abscess formation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Controls</arm_group_label>
    <description>Patients treated for conditions not related to the throat and without signs or symptoms of recent throat disease.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Throat swabbing</intervention_name>
    <arm_group_label>Acute tonsillitis</arm_group_label>
    <arm_group_label>Peritonsillar cellulitis</arm_group_label>
    <arm_group_label>Infectious mononucleosis</arm_group_label>
    <arm_group_label>Controls</arm_group_label>
    <other_name>Blood sample</other_name>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Throat swabs Blood samples
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        100 patients with severe acute tonsillitis 100 patients with peritonsillar cellulitis 50
        patients with infectious mononucleosis
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patients referred to our tertiary care center with acute tonsillitis with or without
             signs of peritonsillar cellulitis and with or without infectious mononucleosis.

          2. Center Score 3 or 4.

        Exclusion Criteria:

          1. Abscess formation.

          2. Previous tonsillectomy.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Aarhus University Hospital</name>
      <address>
        <city>Aarhus</city>
        <zip>8000</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <reference>
    <citation>Klug TE, Henriksen JJ, Rusan M, Fuursted K, Krogfelt KA, Ovesen T, Struve C. Antibody development to Fusobacterium necrophorum in patients with peritonsillar abscess. Eur J Clin Microbiol Infect Dis. 2014 Oct;33(10):1733-9. doi: 10.1007/s10096-014-2130-y. Epub 2014 May 9.</citation>
    <PMID>24810966</PMID>
  </reference>
  <reference>
    <citation>Klug TE. Incidence and microbiology of peritonsillar abscess: the influence of season, age, and gender. Eur J Clin Microbiol Infect Dis. 2014 Jul;33(7):1163-7. doi: 10.1007/s10096-014-2052-8. Epub 2014 Jan 29.</citation>
    <PMID>24474247</PMID>
  </reference>
  <reference>
    <citation>Klug TE, Henriksen JJ, Fuursted K, Ovesen T. Significant pathogens in peritonsillar abscesses. Eur J Clin Microbiol Infect Dis. 2011 May;30(5):619-27. doi: 10.1007/s10096-010-1130-9. Epub 2010 Dec 22.</citation>
    <PMID>21181222</PMID>
  </reference>
  <reference>
    <citation>Ehlers Klug T, Rusan M, Fuursted K, Ovesen T. Fusobacterium necrophorum: most prevalent pathogen in peritonsillar abscess in Denmark. Clin Infect Dis. 2009 Nov 15;49(10):1467-72. doi: 10.1086/644616.</citation>
    <PMID>19842975</PMID>
  </reference>
  <verification_date>March 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 14, 2016</study_first_submitted>
  <study_first_submitted_qc>March 21, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 22, 2016</study_first_posted>
  <last_update_submitted>March 21, 2016</last_update_submitted>
  <last_update_submitted_qc>March 21, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 22, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Aarhus University Hospital</investigator_affiliation>
    <investigator_full_name>Tejs Ehlers Klug</investigator_full_name>
    <investigator_title>Consultant, associate professor</investigator_title>
  </responsible_party>
  <keyword>fusobacterium necrophorum</keyword>
  <keyword>acute tonsillitis</keyword>
  <keyword>peritonsillar cellulitis</keyword>
  <keyword>infectious mononucleosis</keyword>
  <keyword>microbiology</keyword>
  <keyword>antibody development</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Infection</mesh_term>
    <mesh_term>Cellulitis</mesh_term>
    <mesh_term>Tonsillitis</mesh_term>
    <mesh_term>Infectious Mononucleosis</mesh_term>
    <mesh_term>Peritonsillar Abscess</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

